Crenigacestat

Crenigacestat
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T3633-1mg 1 mg

7 - 10 business days*

57.00€
TGM-T3633-5mg 5 mg

7 - 10 business days*

120.00€
TGM-T3633-1mL 1 ml

7 - 10 business days*

122.00€
TGM-T3633-10mg 10 mg

7 - 10 business days*

198.00€
TGM-T3633-25mg 25 mg

7 - 10 business days*

371.00€
TGM-T3633-50mg 50 mg

7 - 10 business days*

-
 
Description: Crenigacestat (LY3039478) is an orally bioavailable Notch inhibitor with an IC50 of... more
Product information "Crenigacestat"
Description: Crenigacestat (LY3039478) is an orally bioavailable Notch inhibitor with an IC50 of ~1 nM in most tumor cell lines tested. It effectively inhibits mutant Notch receptor activity and, in a xenograft tumor model, inhibits the expression of Notch-regulated genes and N1ICD cleavage in the tumor microenvironment. Target: Gamma-secretase. Smiles: C[C@H](NC(=O)CCC(F)(F)F)C(=O)N[C@H]1c2ccccc2-c2cccnc2N(CCO)C1=O. References: Eli Lilly Company. The 8th SCI-RSC Symposium on Proteinase Inhibitor Design. 2013.
Keywords: LY3039478
Supplier: TargetMol
Supplier-Nr: T3633

Properties

Application: Targets Notch 1 (NOTCH1)
MW: 464.44 D
Formula: C22H23F3N4O4

Database Information

CAS : 1421438-81-4| Matching products
KEGG ID : K02599 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Crenigacestat"
Write a review
or to review a product.
Viewed